With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $130,880.12 today based ...

Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...

BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology ...

CM. Read why NTLA stock has potential with upcoming 2025 data and a growing $12B market for Transthyretin Amyloidosis.

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing ...

Regeneron Pharmaceuticals just belly-flopped into a fresh 12-month low, trading as low as $640.28—Wall Street winced. Analyst ...

Students from Salem High School on March 20 participated in the New Hampshire Science and Engineering Expo held at NHTI, ...

An ʻIolani School senior recently took home a top prize at the nation’s oldest science research competition for high school students. Logan Lee traveled to Washington, D.C., earlier this month for the ...

American Century Companies trimmed its stake in Regeneron Pharmaceuticals by 4.2% during Q4, selling nearly 31,000 shares and ...